Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis-Reference-Cited by-同舟云学术

Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis

Published:2013-08-04 Issue:7466 Volume:501 Page:252-256
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Delgoffe Greg M.,Woo Seng-Ryong,Turnis Meghan E.,Gravano David M.,Guy Cliff,Overacre Abigail E.,Bettini Matthew L.,Vogel Peter,Finkelstein David,Bonnevier Jody,Workman Creg J.,Vignali Dario A. A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature12428.pdf

Reference31 articles.

1. Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nature Rev. Immunol. 8, 523–532 (2008)

2. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003)

3. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003)

4. Miyao, T. et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262–275 (2012)

5. Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667–1671 (2010)

Cited by 490 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baker’s yeast beta glucan supplementation was associated with an improved innate immune mRNA expression response after exercise;Methods;2024-10

2. Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma;Heliyon;2024-09

3. Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity;Immunity;2024-09

4. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors;Hepatology Communications;2024-08-26

5. NRP1 antagonism as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis;Allergy;2024-08-21